A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used ...

A ketamine-derived nasal spray is now available for the millions of Americans living with severe depression. The ...

A new study has found small amounts of liquid ketamine administered in a clinical setting can significantly reduce symptoms ...

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...

There's a fine line when it comes to using ketamine and from Chrissy Teigen to Matthew Perry, these stars have explored it.

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

A clinic in Arapahoe County is exploring new ways to help patients by offering ketamine-assisted psychotherapy.

Spravato is now the first stand-alone therapy for treatment-resistant depression, for patients who haven't responded to oral ...

Ketamine therapy has become known for its effects at combating depression and other mood disorders. There’s a growing body of ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.